Cyclo Therapeutics Stock Market Value
| CYTHW Stock | USD 0.14 0.04 22.22% |
| Symbol | Cyclo |
Cyclo Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclo Therapeutics. If investors know Cyclo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.046 | Quarterly Revenue Growth 0.051 | Return On Assets (2.82) | Return On Equity (226.64) |
The market value of Cyclo Therapeutics is measured differently than its book value, which is the value of Cyclo that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cyclo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclo Therapeutics' market value can be influenced by many factors that don't directly affect Cyclo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cyclo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cyclo Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cyclo Therapeutics.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Cyclo Therapeutics on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Cyclo Therapeutics or generate 0.0% return on investment in Cyclo Therapeutics over 30 days. Cyclo Therapeutics is related to or competes with Radcom, BCE, Asure Software, GoHealth, QBE Insurance, Employers Holdings, and Palomar Holdings. Cyclo Therapeutics, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases More
Cyclo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cyclo Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cyclo Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 28.53 | |||
| Information Ratio | 0.0715 | |||
| Maximum Drawdown | 126.19 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 46.07 |
Cyclo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cyclo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cyclo Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cyclo Therapeutics historical prices to predict the future Cyclo Therapeutics' volatility.| Risk Adjusted Performance | 0.0683 | |||
| Jensen Alpha | 1.78 | |||
| Total Risk Alpha | (1.11) | |||
| Sortino Ratio | 0.0515 | |||
| Treynor Ratio | (0.72) |
Cyclo Therapeutics Backtested Returns
Cyclo Therapeutics is out of control given 3 months investment horizon. Cyclo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of standard deviation over the last 3 months. We have analyze and collected data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 2.18% are justified by taking the suggested risk. Use Cyclo Therapeutics risk adjusted performance of 0.0683, and Mean Deviation of 10.85 to evaluate company specific risk that cannot be diversified away. Cyclo Therapeutics holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.16, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Cyclo Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Cyclo Therapeutics is expected to outperform it. Use Cyclo Therapeutics jensen alpha, as well as the relationship between the potential upside and daily balance of power , to analyze future returns on Cyclo Therapeutics.
Auto-correlation | -0.23 |
Weak reverse predictability
Cyclo Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Cyclo Therapeutics time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cyclo Therapeutics price movement. The serial correlation of -0.23 indicates that over 23.0% of current Cyclo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cyclo Therapeutics lagged returns against current returns
Autocorrelation, which is Cyclo Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cyclo Therapeutics' stock expected returns. We can calculate the autocorrelation of Cyclo Therapeutics returns to help us make a trade decision. For example, suppose you find that Cyclo Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cyclo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cyclo Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cyclo Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cyclo Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Cyclo Therapeutics Lagged Returns
When evaluating Cyclo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cyclo Therapeutics stock have on its future price. Cyclo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cyclo Therapeutics autocorrelation shows the relationship between Cyclo Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Cyclo Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cyclo Stock Analysis
When running Cyclo Therapeutics' price analysis, check to measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.